Brevan Howard Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Brevan Howard Capital Management’s Portfolio CRSP Stock Details CRSP Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$268K	Buy
2024 Q4	–	Sell
2024 Q3	$216K	Buy
2024 Q1	–	Sell
2023 Q4	$364K	Buy
2021 Q2	–	Sell
2021 Q1	$1.82M	Sell
2020 Q4	$3.55M	Buy